Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-106,802
Closed -$1.47M 1104
2024
Q2
$1.47M Buy
106,802
+27,202
+34% +$387K ﹤0.01% 825
2024
Q1
$1.21M Sell
79,600
-8,900
-10% -$107K ﹤0.01% 820
2023
Q4
$1M Sell
88,500
-11,500
-12% -$126K ﹤0.01% 845
2023
Q3
$1.19M Sell
100,000
-3,800
-4% -$42.4K ﹤0.01% 808
2023
Q2
$1.08M Buy
103,800
+74,200
+251% +$745K ﹤0.01% 829
2023
Q1
$330K Hold
29,600
﹤0.01% 1010
2022
Q4
$376K Hold
29,600
﹤0.01% 1022
2022
Q3
$297K Buy
+29,600
New +$320K ﹤0.01% 1038
2015
Q1
Sell
-15,325
Closed -$394K 1443
2014
Q4
$394K Hold
15,325
﹤0.01% 1149
2014
Q3
$466K Sell
15,325
-6,314
-29% -$207K ﹤0.01% 1081
2014
Q2
$784K Buy
+21,639
New +$745K ﹤0.01% 981

Other funds holding DNOW

Axa's DNOW Position: Q3 2024 in Review

Axa sold out of DNOW Inc (DNOW) in Q3 2024, closing a stake of 106,802 shares — an estimated $1.47M sold.

Axa first reported a position in DNOW in Q2 2014 and held it in 11 quarters. The position peaked at $1.47M in Q2 2024. 266 funds tracked by Wall St. Rank hold DNOW as of Q3 2024.

  • Axa reported no remaining DNOW Inc position as of Q3 2024 after selling out during the quarter.
  • Axa sold 106,802 DNOW Inc shares in Q3 2024, an estimated $1.47M.
  • Axa first reported a position in DNOW Inc in Q2 2014 and held it in 11 quarters.
  • Axa's DNOW Inc position peaked at $1.47M in Q2 2024.
  • 266 funds tracked by Wall St. Rank held DNOW Inc as of Q3 2024.

Based on Axa's 13F filing for Q3 2024, filed 14 Nov 2024.